Heart failure with preserved ejection fraction

2 trials 1 recruiting MedDRA PT
2 Registered trials
1 Recruiting
2 Unique sponsors
1 Unique IMPs
1 Commercial trials
Drug classes (ATC)
ATC code not specified 1
N Neurology/Psychiatry (ATC N) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase III: 1 Phase I: 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase III

1 trial
  • Medical University Of Gdansk Academic
    SERTRALINE
    2024-515061-33-00 1 country 2024 n=485
    Ended

Phase I

1 trial
  • Merck Sharp & Dohme LLC Commercial
    IMP not specified
    2026-525748-14-00 1 country 2026 n=16
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Merck Sharp & Dohme LLC Commercial 1 Phase I 1
Medical University Of Gdansk Academic 1 Phase III 0
New trials by year
2024
1
2026
1
← All indication landscapes